Showing results (231-240 of 295) with videos related to
Sort By:
Pageof 30
American Journal of Respiratory Cell and Molecular Biology|October 19, 2013
Dysregulation of galectin-3. Implications for Hermansky-Pudlak syndrome pulmonary fibrosisAndrew R Cullinane, Caroline Yeager, Heidi Dorward, et al.Transplantation Direct|July 1, 2025
Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft FailureMichael B Keller, Allison Y Lin, Moon Kyoo Jang, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 16, 2023
Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejectionMichael B Keller, Xin Tian, Moon Kyoo Jang, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunctionMuhtadi Alnababteh, Junfeng Sun, Rohan Meda, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2024
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of diseaseMichael B Keller, David Newman, Muhtadi Alnababteh, et al.Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Management of Acute Pulmonary Embolism, Sara Plett, Nicholas Fidelman, et al.The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.Chest|February 13, 2016
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel ReportClive Kearon, Elie A Akl, Joseph Ornelas, et al.Pageof 30